Interchangeable?

Aripiprazole

Indications (6)

as stated by Otsuka Pharmaceuticals (UK) Ltd

ABILIFY is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
ABILIFY is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment (see section 5.1).
ABILIFY is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older (see section 5.1).

as stated by Thornton & Ross Ltd, Krka UK Ltd, Amarox Limited, Aspire Pharma Ltd

Aripiprazole is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
Aripiprazole is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment (see section 5.1).
Aripiprazole is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older (see section 5.1).

as stated by Neon Healthcare Ltd

Aripiprazole Neon Healthcare is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
Aripiprazole Neon Healthcare is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment (see section 5.1).
Aripiprazole Neon Healthcare is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older (see section 5.1).

as stated by Aurobindo Pharma - Milpharm Ltd.

Aripiprazole Milpharm is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
Aripiprazole is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment (see section 5.1).
Aripiprazole is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older (see section 5.1).

as stated by Sandoz Limited

Aripiprazole Sandoz is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
Aripiprazole Sandoz is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment (see section 5.1).
Aripiprazole Sandoz is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older (see section 5.1).

as stated by Novumgen Limited

Elozar is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
Elozar is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment (see section 5.1).
Elozar is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older (see section 5.1).

6 in all

Quick links

Disagreements (7)

scroll for all 9 products →

Concepts	Manufacturers
Concept	Otsuka Pharmaceuticals (UK) Ltd	Thornton & Ross Ltd	Neon Healthcare Ltd	Krka UK Ltd	Amarox Limited	Aurobindo Pharma - Milpharm Ltd.	Aspire Pharma Ltd	Sandoz Limited	Novumgen Limited
	15mg Tablets10/04/2026	15mg Tablets19/02/2025	15mg Tablets11/06/2025	15mg Tablets28/02/2023	15mg Tablets27/02/2026	15mg Tablets20/05/2026	15mg Tablets22/01/2025	15mg Tablet07/06/2023	15mg Tablet01/06/2026
Enzyme deficiency	The label says it can be used, with care.	The label says it can be used, with care.	Not found in the sections collected. Not evidence the label omits it.	The label says it can be used, with care.	The label says it can be used, with care.	The label says it can be used, with care.	Not found in the sections collected. Not evidence the label omits it.	The label says it can be used, with care.	The label says it can be used, with care.
Intolerance to an ingredient	The label says it can be used, with care.	The label says it can be used, with care.	Not found in the sections collected. Not evidence the label omits it.	The label says it can be used, with care.	The label says it can be used, with care.	The label says it can be used, with care.	The label says it can be used, with care.	The label says it can be used, with care.	The label says it can be used, with care.
Lactose	The label says it can be used, with care.	The label says it can be used, with care.	Not found in the sections collected. Not evidence the label omits it.	The label says it can be used, with care.	The label says it can be used, with care.	The label says it can be used, with care.	The label says it can be used, with care.	The label says it can be used, with care.	The label says it can be used, with care.
Sodium and potassium content	Not found in the sections collected. Not evidence the label omits it.	The label says it can be used, with care.	The label says it can be used, with care.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	The label says it can be used, with care.
Hormone disorders	The label says another medicine affects it.	Not found in the sections collected. Not evidence the label omits it.	The label says another medicine affects it.	Not found in the sections collected. Not evidence the label omits it.	The label says another medicine affects it.	The label says another medicine affects it.	Not found in the sections collected. Not evidence the label omits it.	The label says another medicine affects it.	The label says another medicine affects it.
Sugar alcohols	Not found in the sections collected. Not evidence the label omits it.	The label lists it as an ingredient, not a restriction.	The label lists it as an ingredient, not a restriction.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.
Propylene glycol	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	The label lists it as an ingredient, not a restriction.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.	Not found in the sections collected. Not evidence the label omits it.

Storage and shelf life

Shelf life5 differences

3 yearsFrom 5 manufacturersOtsuka Pharmaceuticals (UK) LtdNeon Healthcare LtdKrka UK LtdAmarox LimitedAspire Pharma Ltd
5 yearsFrom 1 manufacturerThornton & Ross Ltd
3 years.From 1 manufacturerAurobindo Pharma - Milpharm Ltd.
2 yearsAfter first opening of the bottle: 3 monthsFrom 1 manufacturerSandoz Limited
36 monthsFrom 1 manufacturerNovumgen Limited

Special precautions for storage5 differences

Store in the original package in order to protect from moisture.From 3 manufacturersOtsuka Pharmaceuticals (UK) LtdNeon Healthcare LtdAspire Pharma Ltd
This medicinal product does not require any special storage conditions.From 3 manufacturersKrka UK LtdAmarox LimitedNovumgen Limited
This medicinal product does not require any special temperature storage conditions.Store in the original package in order to protect from moisture.From 1 manufacturerThornton & Ross Ltd
This medicinal product does not require any special storage conditionsFrom 1 manufacturerAurobindo Pharma - Milpharm Ltd.
This medicinal product does not require any special storage conditions.For storage conditions after first opening of the bottle, see section 6.3.From 1 manufacturerSandoz Limited

Aripiprazole

Indications (6)

Quick links

Disagreements (7)

Agreements (23)

Storage and shelf life

Shelf life5 differences

Special precautions for storage5 differences

All Aripiprazole products (9)